Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast CancerDaniel P. Silver, Judy E. Garber, Andrea L. Richardson et al.|Journal of Clinical Oncology|2010Cited by 983
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian CancerTimothy R. Rebbeck, Saundra S. Buys, Nandita Mitra et al.|JAMA|2015Cited by 507
A recurrent mutation in PALB2 in Finnish cancer familiesHannele Erkko, Robert Winqvist, Guilan Li et al.|Nature|2007Cited by 461
<i>CHEK2</i>*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast CancerMaren Weischer, Annegien Broeks, Børge G. Nordestgaard et al.|Journal of Clinical Oncology|2012Cited by 180
Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment OutcomeZhigang C. Wang, Nicolai J. Birkbak, Aedín C. Culhane et al.|Clinical Cancer Research|2012Cited by 162